You have found 219 entries after clicking on a search link (usually the MORE information link) in a matrix cell. Sorted by the main topic addressed, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Re-order the list by the most recently added or updated entries or by the most recently published documents
If you have not found what you want you could:
Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or recent bulletins.
Documents are regularly added. Use the e-mail update service to monitor additions.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo
REVIEW 2018 HTM file
Drug consumption rooms: an overview of provision and evidence
Refreshing its overview of the use of drug consumption rooms, the European Union’s drug misuse monitoring centre says the evidence still contradicts concerns that such facilities encourage drug use, delay treatment entry, or aggravate problems arising from local drug markets – finding instead that both the users and the community stand to benefit.
DOCUMENT 1987 HTM file
High time for harm reduction
Impelled by the injecting-related AIDS crisis, Merseyside was where harm reduction in the UK first took root. From there in 1987 came this groundbreaking call for a turn away from what was seen as a failed attempt to prevent use to mitigating the harm. Expressed modestly as a “prudent” suggestion, with Russell Newcombe’s essay, “harm reduction” had come of age.
REVIEW 2019 HTM file
Supervised consumption sites: a nuanced assessment of the causal evidence
How high should the evidence bar be set when deciding whether to endorse drug consumption rooms?
HOT TOPIC 2020 HTM file
Time for safer injecting spaces in Britain?
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Drug consumption rooms are a particularly contentious form of harm reduction, viewed on one hand as a practical, humane, life-saving approach to dangerous drug use, and on the other, as an endorsement of drugtaking and a dereliction of the duty to treat people dependent on drugs.
‘How can the design of drug consumption rooms be optimised to maximise their benefits?’ – a question that has tended to be overlooked in the wider debate about whether consumption rooms should be established in the first place. The featured study goes inside North America’s first women-only safer injecting facility, which emerged in response to an epidemic of fatal drug overdoses and an epidemic of violence against women.
STUDY 2008 HTM file
High risk of overdose death for opiate detoxification completers
Findings from Italy and Australia warn that detoxification without throughgoing stabilisation, preparation and aftercare is too often a band-aid measure which risks more harm then good.
IN PRACTICE 2004 PDF file 418Kb
Giving the silent majority a voice
Constrained by guidelines and standards, a UK prescribing service could do little to respond to user survey feedback.
STUDY 1999 PDF file 255Kb
Methadone treatment cost-effective life saver
Three studies which show that getting in to and staying in methadone treatment cost-effectively saves the lives of heroin addicts. Conversely, being denied treatment or discharged for rule-breaking costs lives.
STUDY 2000 PDF file 111Kb
Careful induction prevents overdose deaths among methadone patients
Studies from Australia and Scotland both find that overdose death during methadone maintenance is closely related to continued illegal drug use in the early stages of treatment.
STUDY 2001 PDF file 161Kb
Under-dosing and poor initial assessment undermine success of British methadone services
Reports from the NTORS study in England confirm that the benefits of methadone prescribing persist to two years after treatment entry though nearly a fifth of patients do not respond well to an often ill-defined programme not delivered as intended.
Select search results pagePREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22